Testing Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Testing Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Testing Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Testing Laboratories
Testing Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2021-03-02 NEO / NeoGenomics, Inc. 4 Dieter Cynthia J A - Award D 53.17 7,034
2021-03-02 NEO / NeoGenomics, Inc. 4 Bonello William A - Award D 53.17 24,619
2021-03-02 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE A - Award D 53.17 35,171
2021-03-02 NEO / NeoGenomics, Inc. 4 Bonello William A - Award D 4,345
2021-03-02 NEO / NeoGenomics, Inc. 4 Dieter Cynthia J A - Award D 1,241
2021-03-01 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B F - Taxes D -169
2021-03-01 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER F - Taxes D -212
2021-03-01 NEO / NeoGenomics, Inc. 4 Bonello William F - Taxes D -500
2021-03-01 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M F - Taxes D -2,339
2021-03-01 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. F - Taxes D -742
2021-03-01 NEO / NeoGenomics, Inc. 4 Pedulla Denise E F - Taxes D -212
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C M - Exercise D 22.52 4,269
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C M - Exercise D -4,269
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C M - Exercise D -3,017
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C M - Exercise D -10,000
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund M - Exercise I -100,000
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C M - Exercise D 7.27 10,000
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund M - Exercise I 7.15 100,000
2021-01-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C M - Exercise D 11.60 3,017
2021-01-05 APDN / Applied DNA Sciences, Inc. 4 Hayward James A A - Award D 80,000
2020-12-30 DIGP / Hypha Labs, Inc. 4 RABEN BRUCE I A - Award D 0.0225 900,000
2020-12-25 DIGP / Hypha Labs, Inc. 4 Peterson Todd A A - Award D 728,155
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 13.87 16,666
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -16,666
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -13,333
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 6.98 50,000
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -20,000
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -50,000
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 9.22 13,333
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 19.60 9,005
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 7.27 20,000
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -9,005
2020-12-14 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 51.67 -25,000
2020-12-14 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin S - Sale D 51.06 -20,200
2020-12-11 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D 8.03 15,000
2020-12-11 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D -15,000
2020-12-11 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 50.52 -25,000
2020-12-11 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER S - Sale D 49.99 -15,000
2020-12-10 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 50.30 -20,000
2020-12-07 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 49.45 -45,658
2020-12-04 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 48.07 -64,394
2020-12-04 NEO / NeoGenomics, Inc. 4 Johnson Kevin C S - Sale D 47.88 -24,683
2020-12-03 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 48.03 -19,948
2020-12-02 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D 8.03 8,000
2020-12-02 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D -8,000
2020-12-02 NEO / NeoGenomics, Inc. 4 Bonello William S - Sale D 46.80 -8,000
2020-11-25 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D 7.52 77,074
2020-11-25 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D -77,074
2020-11-25 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE S - Sale D 45.48 -77,074
2020-11-24 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D 7.52 72,926
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)